Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Royal Bank of Canada

Royal Bank of Canada increased its stake in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 328.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 173,514 shares of the scientific and technical instruments company's stock after acquiring an additional 133,013 shares during the quarter. Royal Bank of Canada owned about 1.86% of Transcat worth $18,348,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Jones Financial Companies Lllp lifted its stake in Transcat by 686.7% in the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after purchasing an additional 309 shares during the last quarter. Aquatic Capital Management LLC raised its position in Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after buying an additional 1,052 shares during the last quarter. Morgan Dempsey Capital Management LLC acquired a new position in shares of Transcat in the 4th quarter valued at $143,000. SG Americas Securities LLC purchased a new position in shares of Transcat during the 4th quarter valued at approximately $182,000. Finally, KLP Kapitalforvaltning AS purchased a new position in Transcat in the 4th quarter valued at $190,000. 98.34% of the stock is owned by institutional investors.

Transcat Stock Performance

TRNS traded up $0.05 on Friday, reaching $88.50. The company had a trading volume of 11,043 shares, compared to its average volume of 81,802. The stock has a 50-day moving average price of $81.02 and a 200-day moving average price of $89.24. Transcat, Inc. has a 1 year low of $67.56 and a 1 year high of $147.12. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $823.82 million, a PE ratio of 47.90 and a beta of 0.69.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.02). The company had revenue of $77.13 million during the quarter, compared to analysts' expectations of $76.40 million. Transcat had a net margin of 6.22% and a return on equity of 7.23%. The company's quarterly revenue was up 8.8% on a year-over-year basis. As a group, research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on TRNS shares. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a research report on Wednesday. HC Wainwright reaffirmed a "buy" rating and issued a $116.00 target price (up previously from $106.00) on shares of Transcat in a report on Wednesday, May 21st. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Transcat presently has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.